EZH2 and lung carcinoma: As determined in our meta-analysis, we concluded that EZH2 overexpression was associated with poor overall survival in lung cancer, this effect appears also significant when the analysis is restricted in Asian population, lung AC and stage I patients, but not among Caucasians.